Lion Point Capital’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-82,425
| Closed | -$1.95M | – | 35 |
|
2023
Q4 | $1.95M | Hold |
82,425
| – | – | 0.97% | 10 |
|
2023
Q3 | $1.23M | Sell |
82,425
-17,000
| -17% | -$253K | 0.55% | 11 |
|
2023
Q2 | $1.09M | Hold |
99,425
| – | – | 0.49% | 14 |
|
2023
Q1 | $867K | Sell |
99,425
-120,000
| -55% | -$1.05M | 0.36% | 20 |
|
2022
Q4 | $704K | Hold |
219,425
| – | – | 0.1% | 22 |
|
2022
Q3 | $704K | Buy |
+219,425
| New | +$704K | 0.16% | 25 |
|